Nick has worked in ophthalmology since 2001 in a variety of project management, clinical development and business operations roles for small and large service organizations. He and his teams have been responsible for programs leading to approvals of a number of ophthalmic drugs, devices and diagnostics across retinal indications, glaucoma, dry eye, and orphan diseases. Nick is a member of Syneos Health’s Rare Disease and Biosimilar consortiums, and regularly consults with customers on regulatory strategy, study execution, and market positioning for eye care products.